Aronia, Cognition, and Eye Health (ACE)
NCT05683002 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2026-01-16
Summary
There is great interest in improving cognitive performance and eye health as working from home becomes more prominent. Working from home as well as stress in the workplace is an increasing problem. Students and work professional can therefore benefit from improved attention and thus performance in academic and other work environments. A completely natural supplement with aronia melanocarpa extract could be a promising way to naturally improve cognitive performance
Conditions
- Cognitive Function
Interventions
- DIETARY_SUPPLEMENT
-
Aronia supplementation
As described in experimental arm
- DIETARY_SUPPLEMENT
-
Cellulose supplementation
As described in placebo comparator arm
Sponsors & Collaborators
-
BioActor B.V.
collaborator INDUSTRY -
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Jogchum Plat, Prof · Maastricht University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-08
- Primary Completion
- 2024-07-26
- Completion
- 2026-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Evaluation of the Effects of a Food Supplementation on the Improvement of Cognitive Functions in Healthy Seniors
NCT05472285 ·Status: COMPLETED ·Phase: NA
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI
NCT05594355 ·Status: UNKNOWN ·Phase: PHASE4
-
Huperzine A in Alzheimer's Disease
NCT00083590 ·Status: COMPLETED ·Phase: PHASE2
-
Healthy Adults With Mild Cognitive Impairment (MCI) and a 16-week Intervention With Mitocholine™, a Functional Food Ingredient
NCT05690724 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
NCT04805983 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease
NCT04693520 ·Status: COMPLETED ·Phase: PHASE2
-
B-vitamins Treatment for Improvement of Cognitive Function
NCT01095211 ·Status: COMPLETED ·Phase: NA
-
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease
NCT07062198 ·Status: RECRUITING ·Phase: PHASE3
-
Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856
NCT05783830 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Network-Level Mechanisms for Preclinical Alzheimer's Disease Development
NCT03461861 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of AQW051 in Patients With Memory Impairment
NCT00582855 ·Status: TERMINATED ·Phase: PHASE2
-
ANAVEX2-73 for Treatment of Early Alzheimer's Disease
NCT03790709 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment
NCT02291783 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of MEMORMAX in Subjects With MCI
NCT03581929 ·Status: COMPLETED ·Phase: NA
-
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
NCT02788513 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
NCT00777361 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of NTRX-07 in Participants With Alzheimer's Disease
NCT07058688 ·Status: RECRUITING ·Phase: PHASE2
-
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
NCT04279418 ·Status: COMPLETED ·Phase: NA
-
Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease
NCT01538212 ·Status: COMPLETED
-
Bisnorcymserine in Healthy Adult Volunteers
NCT01747213 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease
NCT06694597 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.
NCT07258004 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease
NCT00752232 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
NCT05591027 ·Status: RECRUITING ·Phase: PHASE1